Jucaite A - Search Results

1

A PET study in healthy subjects of brain exposure of ¹¹C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer.

Varrone A, Varnäs K, Jucaite A, Cselényi Z, Johnström P, Schou M, Vazquez-Romero A, Moein MM, Halldin C, Brown AP, Vishwanathan K, Farde L. Varrone A, et al. Among authors: jucaite a. J Cereb Blood Flow Metab. 2020 Apr;40(4):799-807. doi: 10.1177/0271678X19843776. Epub 2019 Apr 20. J Cereb Blood Flow Metab. 2020. PMID: 31006308 Free PMC article.

2

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.

Talvik M, Nordström AL, Larsen NE, Jucaite A, Cervenka S, Halldin C, Farde L. Talvik M, et al. Among authors: jucaite a. Psychopharmacology (Berl). 2004 Sep;175(2):148-53. doi: 10.1007/s00213-004-1802-1. Epub 2004 Mar 6. Psychopharmacology (Berl). 2004. PMID: 15007534 Clinical Trial.

3

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.

Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Jucaite A, et al. Biol Psychiatry. 2005 Feb 1;57(3):229-38. doi: 10.1016/j.biopsych.2004.11.009. Biol Psychiatry. 2005. PMID: 15691523

4

Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.

Jucaite A, Odano I, Olsson H, Pauli S, Halldin C, Farde L. Jucaite A, et al. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):657-68. doi: 10.1007/s00259-005-0027-9. Epub 2006 Mar 3. Eur J Nucl Med Mol Imaging. 2006. PMID: 16514530 Clinical Trial.

5

Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy.

Ciumas C, Wahlin TB, Jucaite A, Lindstrom P, Halldin C, Savic I. Ciumas C, et al. Among authors: jucaite a. Neurology. 2008 Sep 9;71(11):788-94. doi: 10.1212/01.wnl.0000316120.70504.d5. Epub 2008 May 7. Neurology. 2008. PMID: 18463366

6

Changes in cortical dopamine D1 receptor binding associated with cognitive training.

McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, Klingberg T. McNab F, et al. Among authors: jucaite a. Science. 2009 Feb 6;323(5915):800-2. doi: 10.1126/science.1166102. Science. 2009. PMID: 19197069

7

Jucaite A, Forssberg H, Karlsson P, Halldin C, Farde L. Jucaite A, et al. Neuroscience. 2010 Apr 28;167(1):104-10. doi: 10.1016/j.neuroscience.2010.01.034. Epub 2010 Jan 28. Neuroscience. 2010. PMID: 20109534

8

Comparison of D₂ dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects.

Nord M, Nyberg S, Brogren J, Jucaite A, Halldin C, Farde L. Nord M, et al. Among authors: jucaite a. Int J Neuropsychopharmacol. 2011 Nov;14(10):1357-66. doi: 10.1017/S1461145711000514. Epub 2011 Apr 11. Int J Neuropsychopharmacol. 2011. PMID: 21477416 Free PMC article. Clinical Trial.

9

Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy.

Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, Halldin C, Farde L. Odano I, et al. Among authors: jucaite a. Neuroimage. 2012 Feb 15;59(4):3582-93. doi: 10.1016/j.neuroimage.2011.10.067. Epub 2011 Oct 28. Neuroimage. 2012. PMID: 22056530

10

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects.

Jučaite A, Cselényi Z, Arvidsson A, Ahlberg G, Julin P, Varnäs K, Stenkrona P, Andersson J, Halldin C, Farde L. Jučaite A, et al. EJNMMI Res. 2012 Apr 23;2:15. doi: 10.1186/2191-219X-2-15. EJNMMI Res. 2012. PMID: 22524272 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page